A medic at Burjeel Hospital in central Abu Dhabi holds a dose of a vaccine developed by Chinese drug maker Sinopharm. Victor Besa / The National
A medic at Burjeel Hospital in central Abu Dhabi holds a dose of a vaccine developed by Chinese drug maker Sinopharm. Victor Besa / The National
Burjeel IPO: UAE healthcare provider raises $300m from oversubscribed offering
Offering was more than 29 times oversubscribed, drawing strong demand from the UAE and region, with total gross demand at more than $8.7bn
